 LEXINGTON, Mass., Sept. 08, 2021 GLOBE NEWSWIRE -- T2 Biosystems, Inc. NASDAQ:TTOO, a leader in the rapid detection of sepsis-causing pathogens, announced today plans to consolidate its existing facilities and expand into a newly leased facility in Billerica, Massachusetts. The Company will consolidate its existing operations in Lexington, MA and Wilmington, MA into a 70,000 sq.ft. facility in Billerica, MA to accommodate current and future growth. The move is expected to occur during the second half of 2022. 